PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.
PPAR signaling
cardiac maturation
fatty acid oxidation
metabolism
stem cells
Journal
Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472
Informations de publication
Date de publication:
07 04 2022
07 04 2022
Historique:
received:
19
11
2020
revised:
30
06
2021
accepted:
24
02
2022
pubmed:
25
3
2022
medline:
13
4
2022
entrez:
24
3
2022
Statut:
ppublish
Résumé
Pluripotent stem-cell-derived cardiomyocytes (PSC-CMs) provide an unprecedented opportunity to study human heart development and disease, but they are functionally and structurally immature. Here, we induce efficient human PSC-CM (hPSC-CM) maturation through metabolic-pathway modulations. Specifically, we find that peroxisome-proliferator-associated receptor (PPAR) signaling regulates glycolysis and fatty acid oxidation (FAO) in an isoform-specific manner. While PPARalpha (PPARa) is the most active isoform in hPSC-CMs, PPARdelta (PPARd) activation efficiently upregulates the gene regulatory networks underlying FAO, increases mitochondrial and peroxisome content, enhances mitochondrial cristae formation, and augments FAO flux. PPARd activation further increases binucleation, enhances myofibril organization, and improves contractility. Transient lactate exposure, which is frequently used for hPSC-CM purification, induces an independent cardiac maturation program but, when combined with PPARd activation, still enhances oxidative metabolism. In summary, we investigate multiple metabolic modifications in hPSC-CMs and identify a role for PPARd signaling in inducing the metabolic switch from glycolysis to FAO in hPSC-CMs.
Identifiants
pubmed: 35325615
pii: S1934-5909(22)00097-2
doi: 10.1016/j.stem.2022.02.011
pii:
doi:
Substances chimiques
PPAR delta
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
559-576.e7Subventions
Organisme : NCI NIH HHS
ID : R01 CA267696
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA271346
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134956
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL128646
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interest.